Clinical Trials
67 trialsSCOOT
University of Oxford
CREATE
AstraZeneca
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Pfizer
FOREFRONT
AstraZeneca
MYLUNG
US Oncology Research
OvAR-Y
Washington University School of Medicine
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
ASCENT
University College, London
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment
Pfizer
PLuS2
University of Florida
Using e-Nose Technology to Identify Early Lung Cancer
Memorial Sloan Kettering Cancer Center
Early Detection of Lung Cancer
Vanderbilt-Ingram Cancer Center
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study
M.D. Anderson Cancer Center
SHIELD
Guardant Health, Inc.
ELEPHAS-02
Elephas
Multimodal CT-Based Risk Stratification for Postoperative Local Recurrence in NSCLC: A Multicenter Study
Jinling Hospital, China
Circulating Tumor Cells (CTC) in Lung Cancer
Indiana University
Real World Registry for Use of the Ion Endoluminal System
Intuitive Surgical
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
RATS_RYC
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
SWOG Cancer Research Network
Reminder Messages for Lung Cancer Screening
M.D. Anderson Cancer Center
AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
DELFI-L201
Delfi Diagnostics Inc.
IPF-LC-IO
The First Affiliated Hospital with Nanjing Medical University
Palliative Thoracic ImmunoRT
University Health Network, Toronto
FLAR-4DCT
The Second Affiliated Hospital of Chongqing Medical University
Clinician-Patient Communication in Lung Cancer Care
Memorial Sloan Kettering Cancer Center
AB1MALT
Creo Medical Limited
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
AstraZeneca
VALKIM
Royal North Shore Hospital
LUCAS-PEN
Seoul National University Hospital
Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
INHERIT
Dana-Farber Cancer Institute
Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
The First Affiliated Hospital of Soochow University
Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer Surgery
Ondokuz Mayıs University
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Nucleix Ltd.
CLARITY
Abramson Cancer Center at Penn Medicine
PRACTICAL
The Christie NHS Foundation Trust
RADICAL
NHS Greater Glasgow and Clyde
RESISTYR
Rennes University Hospital
FANSS
NYU Langone Health
Match 2
Noah Medical
Genetic Susceptibility to Lung Cancer in Never Smokers
Memorial Sloan Kettering Cancer Center
Validation of a Multi-gene Test for Lung Cancer Risk
University of Toledo
Interventional Ablation for Early-stage Lung Cancer
Guangzhou Institute of Respiratory Disease
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI